Has Travis Mills received payments from drug or device companies?

Yes. Drug and device makers reported $673 in general payments to Travis Mills across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Travis Mills did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Travis Mills come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Travis Mills

Nurse Anesthetist, Certified Registered · Myrtle Beach, SCNPI 1003209412

Payments from drug & device makers

$673in general payments, 2019–2025

Across 39 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$187
Abbott$77
Aimmune Therapeutics, Inc.$69
Madrigal Pharmaceuticals$61
Merck$51
Intercept Pharmaceuticals, Inc.$49
plus $180 from 8 others

What the payments were for

Food & beverage$673100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	12	$187
Abbott	5	$77
Aimmune Therapeutics, Inc.	3	$69
Madrigal Pharmaceuticals	3	$61
Merck	3	$51
Intercept Pharmaceuticals, Inc.	3	$49
Celltrion USA Inc.	2	$39
Cardiovascular Systems Inc.	2	$33
Lilly USA, LLC	1	$24
Nestle Healthcare Nutrition Inc.	1	$21
Redhill Biopharma Inc.	1	$18
Johnson & Johnson	1	$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15
Regeneron Healthcare Solutions, Inc.	1	$15

How this compares

$673 in reported general payments places this provider in the 85th percentile of 1,318 nurse anesthetist, certified registered providers in South Carolina.

See all nurse anesthetist, certified registered providers in South Carolina →

Medicare billing

Part B allowed, 2024

$45,109

Medicare patients

429

Services billed

431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse anesthetist, certified registered in Myrtle Beach

Patrick QuinnMyrtle Beach$10K
Jaime GremillionMyrtle Beach$4K
Lia HightMyrtle Beach$2K
Everett MossSpartanburg$31K
Sara KrafftColumbia$29K
Anna FraifeldGreenville$28K
Erica HarrisGreenville$17K
Jeffrey BoswellAiken$15K
Benita DavisGreenville$7K
Aimee GondiWest Columbia$7K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →